Catharanthus Role in Cancer Treatment, Synonyms and Medicinal Uses

Biological Name : Catharanthus roseus

Family : Apocyanaceae

Catharanthus roseus (Madagascar Periwinkle), Nayantara in Bengali, is common flower in India. Photographed at Kolkata. (Photo credit: Wikipedia)

Synonyms of Catharanthus:

• Hindi – Sadabahar
• Oriya – Ainskati
• Bengali – Nayantara
• Malayalam – Ushamalari
• Marathi – Sada-phul
• Tamil – Sudukadu mallikal
• Telugu – Billaganneru

Catharanthus is an erect herb with a height of one metre. Flowers are white or purple-red in colour. It is grown throughout the India and is mainly cultivated in gardens. The useful parts of the plant are roots and leaves.

Properties of Catharanthus:

• Stomachic
• Hypoglycemic
• Sedative
• Anti-cancerous

Phytochemicals in Catharanthus:

The phytochemicals which are present in the catharanthus are alkaloids like vincristine and vinblstine.

Forms of use: It is used in the form of decoction from root and leaves and as powder.

Medicinal uses:

In Cancer

• The violet flowers of the plant contains alkaloids, vincristine and vinblastine which are powerful anti-cancerous agents.
• Vincristine and vinblastine are powerful cytotoxic agents and they arrest the rapidly dividing cells in cancer.
• These are useful in the treatment of Hodgkin’s disease, non-Hodgkin’s syndrome, lymphomas, leukaemia, breast cancer and other related problems.

Other Medicinal Uses of Catharanthus:

• The drug is used as a hypoglycemic agent in diabetes.
• Catharanthus acts as a sedative.
• Catharanthus is used for treating stomachache.

Related posts

• Galera Therapeutics enrolls patients for pancreatic cancer trial of GC4419 (0)
• ABM Therapeutics begins phase 1 trial of BRAF inhibitor ABM-1310 (0)
• Ascentage, Acerta to evaluate APG-2575, CALQUENCE combo in r/r CLL/SLL (0)
• Roche gets FDA nod for cobas EZH2 Mutation Test as companion diagnostic for follicular lymphoma patients (0)
• Leap Therapeutics gets FDA orphan status for DKN-01 for gastric and gastroesophageal junction cancer (0)
• Takeda gets extended EC approval for ADCETRIS in sALCL (0)
• PADCEV, KEYTRUDA combination for advanced bladder cancer gets FDA breakthrough therapy status (0)
• Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer (0)
• What is Cancer? Types of Cancer & Symptoms of Cancer (0)
• Merck acquires ArQule for $2.7bn to further diversify oncology pipeline (0)